<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31534049</article-id>
<article-id pub-id-type="pmc">6795381</article-id>
<article-id pub-id-type="publisher-id">128568</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.128568</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Inhibition of 4-aminobutyrate aminotransferase protects against injury-induced osteoarthritis in mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Jie</given-names>
</name>
<email>shenj@wudosis.wustl.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Cuicui</given-names>
</name>
<email>wangcu@wudosis.wustl.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ying</surname>
<given-names>Jun</given-names>
</name>
<email>junying@wustl.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Taotao</given-names>
</name>
<email>xutzjtcm@163.com</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McAlinden</surname>
<given-names>Audrey</given-names>
</name>
<email>mcalindena@wudosis.wustl.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Keefe</surname>
<given-names>Regis J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Orthopaedic Surgery, School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.</aff>
<aff id="A2"><label>2</label>Institute of Orthopaedics and Traumatology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.</aff>
<aff id="A3"><label>3</label>Zhejiang Chinese Medical University, Hangzhou, China.</aff>
<aff id="A4"><label>4</label>Department of Cell Biology and Physiology, School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Regis J. O’Keefe, Department of Orthopaedic Surgery, Washington University in St. Louis, 660 South Euclid, CB 8233, St. Louis, Missouri 63110, USA. Phone: 314.747.8414; Email: <email>rokeefe@wustl.edu</email>.</corresp>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2019-09-19T09:00:00-0400" publication-format="electronic">
<day>19</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2019-09-19T09:00:00-0400" publication-format="electronic">
<day>19</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>9</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>4</volume>
<issue>18</issue>
<elocation-id>e128568</elocation-id>
<history>
<date date-type="received">
<day>4</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 American Society for Clinical Investigation</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/128568">This article is available online at https://insight.jci.org/articles/view/128568</self-uri>
<abstract>
<p>Recently we demonstrated that ablation of the DNA methyltransferase enzyme, Dnmt3b, resulted in catabolism and progression of osteoarthritis (OA) in murine articular cartilage through a mechanism involving increased mitochondrial respiration. In this study, we identify 4-aminobutyrate aminotransferase (Abat) as a downstream target of Dnmt3b. Abat is an enzyme that metabolizes γ-aminobutyric acid to succinate, a key intermediate in the tricarboxylic acid cycle. We show that Dnmt3b binds to the <italic>Abat</italic> promoter, increases methylation of a conserved CpG sequence just upstream of the transcriptional start site, and inhibits <italic>Abat</italic> expression. <italic>Dnmt3b</italic> deletion in articular chondrocytes results in reduced methylation of the CpG sequence in the <italic>Abat</italic> promoter, which subsequently increases expression of <italic>Abat</italic>. Increased Abat expression in chondrocytes leads to enhanced mitochondrial respiration and elevated expression of catabolic genes. Overexpression of Abat in murine knee joints via lentiviral injection results in accelerated cartilage degradation following surgical induction of OA. In contrast, lentiviral-based knockdown of Abat attenuates the expression of IL-1β–induced catabolic genes in primary murine articular chondrocytes in vitro and also protects against murine articular cartilage degradation in vivo. Strikingly, treatment with the FDA-approved small-molecule Abat inhibitor, vigabatrin, significantly prevents the development of injury-induced OA in mice. In summary, these studies establish Abat as an important new target for therapies to prevent OA.</p>
</abstract>
<abstract abstract-type="toc">
<p>Abat is downstream target of the DNA methyltransferase enzyme Dnmt3b, and its inhibition attenuates injury-induced articular cartilage degeneration in mice.</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Bone Biology</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Arthritis</kwd>
<kwd>Cartilage</kwd>
<kwd>Homeostasis</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>NIH/NIAMS</funding-source>
<award-id>AR069605</award-id>
</award-group>
<award-group>
<funding-source>NIH/NIAMS</funding-source>
<award-id>AR057235</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>